WINTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
WINDTREE THERAPEUTICS INC /DE/
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 19, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $26.68K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Windtree Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rockledge Capital Corporation | 339,167 | 6.18% | 13G (passive) amendment | Dec 31, 2023 |
| Krishna Duvvuri | 326,900 | 6.35% | 13G (passive) | Oct 9, 2023 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andrew Albert Kucharchuk | Director | – | – | Aug 5, 2025 |
| Leanne Kelly | Director | – | – | Jan 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Craig Fraser President and CEO, Director | Oct 8, 2024 | Buy | +5,431 | $0.91 | $4.94K | 8,638 |
| Craig Fraser President and CEO, Director | Sep 27, 2023 | Buy | +2,500 | $1.02 | $2.55K | 57,877 |
| Craig Fraser President and CEO, Director | Sep 26, 2023 | Buy | +2,500 | $0.90 | $2.25K | 55,377 |
| Daniel E. Geffken Director | Aug 23, 2023 | Award | +2,033 | – | – | 2,175 |
| Mark Strobeck Director | Aug 23, 2023 | Award | +2,300 | – | – | 2,300 |
| Eric Curtis SVP & COO | Aug 23, 2023 | Award | +14,667 | – | – | 15,920 |
| Steven Simonson SVP, Chief Medical Officer | Aug 23, 2023 | Award | +15,867 | – | – | 17,440 |
| Robert A. Scott Director | Aug 23, 2023 | Award | +2,033 | – | – | 2,133 |
| Craig Fraser President and CEO, Director | Aug 23, 2023 | Award | +45,867 | – | – | 52,877 |
| Leslie J. Williams Director | Aug 23, 2023 | Award | +2,033 | – | – | 2,133 |
| Craig Fraser President and CEO, Director | Apr 26, 2023 | Buy | +1,497 | $1.77 | $2.65K | 7,010 |
| Craig Fraser President and CEO, Director | Apr 25, 2023 | Buy | +1,315 | $1.89 | $2.49K | 5,513 |
| Craig Fraser President and CEO, Director | Feb 28, 2023 | Tax withholding | −334 | – | – | 4,198 |
| Diane Carman SVP & General Counsel | Feb 28, 2023 | Tax withholding | −99 | – | – | 1,227 |
| Steven Simonson SVP, Chief Medical Officer | Feb 28, 2023 | Tax withholding | −100 | – | – | 1,573 |
| Eric Curtis SVP & COO | Feb 28, 2023 | Tax withholding | −99 | – | – | 1,253 |
| James Huang Director | Feb 22, 2023 | Option exercise | +1,112,308 | $0.14 | $155.72K | 3,449,161 |
| Craig Fraser President and CEO, Director | Jul 27, 2022 | Buy | +2,500 | $0.38 | $950 | 226,558 |
| John P. Hamill SVP & CFO | Jul 26, 2022 | Buy | +3,000 | $0.37 | $1.11K | 72,800 |
| Craig Fraser President and CEO, Director | Jul 26, 2022 | Buy | +2,500 | $0.37 | $925 | 224,058 |
| Craig Fraser President and CEO, Director | Jun 30, 2022 | Buy | +4,500 | $0.43 | $1.94K | 221,558 |
| Craig Fraser President and CEO, Director | Jun 29, 2022 | Buy | +7,000 | $0.42 | $2.94K | 217,058 |
| Robert A. Scott Director | Jun 7, 2022 | Award | +5,000 | – | – | 5,000 |
| Leslie J. Williams Director | Jun 7, 2022 | Award | +5,000 | – | – | 5,000 |
| James Huang Director | Jun 7, 2022 | Award | +5,000 | – | – | 296,281 |
| Daniel E. Geffken Director | Jun 7, 2022 | Award | +5,000 | – | – | 7,069 |
| Craig Fraser President and CEO, Director | Mar 16, 2022 | Buy | +2,000 | $0.98 | $1.96K | 210,058 |
| Craig Fraser President and CEO, Director | Mar 15, 2022 | Buy | +3,000 | $0.98 | $2.94K | 208,058 |
| Steven Simonson SVP, Chief Medical Officer | Mar 15, 2022 | Buy | +5,000 | $1.00 | $5.00K | 83,602 |
| Steven Simonson SVP, Chief Medical Officer | Mar 4, 2022 | Award | +66,300 | – | – | 78,602 |
| Diane Carman SVP & General Counsel | Mar 4, 2022 | Award | +66,300 | – | – | 66,300 |
| Craig Fraser President and CEO, Director | Mar 4, 2022 | Award | +166,900 | – | – | 205,058 |
| John P. Hamill SVP & CFO | Mar 4, 2022 | Award | +66,300 | – | – | 69,800 |
| Eric Curtis SVP & COO | Mar 4, 2022 | Award | +66,300 | – | – | 67,591 |
| Capital Inc. Bioengine 10% owner | Dec 30, 2021 | Sale | −1,239,088 | $1.60 | $1.98M | 0 |
| Center Laboratories, Inc. 10% owner | Dec 30, 2021 | Buy | +1,239,088 | $1.60 | $1.98M | 1,239,088 |
| Craig Fraser President and CEO, Director | Nov 19, 2021 | Buy | +930 | $1.60 | $1.49K | 38,158 |
| Craig Fraser President and CEO, Director | Nov 18, 2021 | Buy | +930 | $1.61 | $1.50K | 37,228 |
| Craig Fraser President and CEO, Director | Oct 22, 2021 | Buy | +3,000 | $1.90 | $5.70K | 36,298 |
| Craig Fraser President and CEO, Director | Oct 19, 2021 | Buy | +3,000 | $1.91 | $5.73K | 33,298 |
| James Huang Director | Oct 19, 2021 | Buy | +50,000 | $1.90 | $95.00K | 291,281 |
| Craig Fraser President and CEO, Director | Apr 16, 2021 | Buy | +1,000 | $2.09 | $2.09K | 30,298 |
| John P. Hamill SVP & CFO | Apr 16, 2021 | Buy | +1,000 | $2.07 | $2.07K | 3,500 |
| Craig Fraser President and CEO, Director | Apr 15, 2021 | Buy | +1,000 | $2.24 | $2.24K | 29,298 |
| Eric Curtis SVP & COO | Apr 7, 2021 | Buy | +791 | $2.52 | $1.99K | 1,291 |
| Craig Fraser President and CEO, Director | Apr 6, 2021 | Buy | +500 | $2.57 | $1.29K | 28,298 |
| Craig Fraser President and CEO, Director | Apr 5, 2021 | Buy | +1,000 | $2.58 | $2.58K | 27,798 |
| Craig Fraser President and CEO, Director | Apr 1, 2021 | Buy | +500 | $2.46 | $1.23K | 26,798 |
| James Huang Director, 10% owner | Mar 31, 2021 | Buy | +150,000 | $2.36 | $354.00K | 171,000 |
| Craig Fraser President and CEO, Director | Mar 31, 2021 | Buy | +500 | $2.32 | $1.16K | 26,298 |
| Steven Simonson SVP, Chief Medical Officer | Mar 25, 2021 | Buy | +1,500 | $3.25 | $4.88K | 12,302 |
| Craig Fraser President and CEO, Director | Mar 25, 2021 | Buy | +1,500 | $3.25 | $4.88K | 25,798 |
| John P. Hamill SVP & CFO | Mar 25, 2021 | Buy | +1,500 | $3.25 | $4.88K | 2,500 |
| Craig Fraser President and CEO, Director | Oct 28, 2020 | Buy | +250 | $6.56 | $1.64K | 24,298 |
| James Huang Director, 10% owner | Oct 23, 2020 | Buy | +1,000 | $6.67 | $6.67K | 21,000 |
| Craig Fraser President and CEO, Director | Oct 9, 2020 | Buy | +250 | $5.83 | $1.46K | 24,048 |
| Eric Curtis SVP & COO | Oct 8, 2020 | Buy | +500 | $5.27 | $2.64K | 500 |
| Craig Fraser President and CEO, Director | Oct 7, 2020 | Buy | +250 | $5.17 | $1.29K | 23,798 |
| John P. Hamill SVP & CFO | Oct 7, 2020 | Buy | +1,000 | $5.27 | $5.27K | 1,000 |
| James Huang Director, 10% owner | Jun 4, 2020 | Buy | +12,000 | $7.32 | $87.84K | 20,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.